Sana Biotechnology (SANA) News Today $1.84 +0.04 (+1.93%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$1.88 +0.03 (+1.63%) As of 03/27/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Class Action Filed Against Sana Biotechnology, Inc. (SANA) Seeking Recovery for Investors - Contact Levi & KorsinskyMarch 28 at 5:45 AM | prnewswire.comSHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana BiotechnologyMarch 27 at 1:34 PM | globenewswire.comLost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Suit Seeking Recovery – Contact Levi & KorsinskyMarch 27 at 12:45 PM | globenewswire.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANAMarch 27 at 5:45 AM | prnewswire.comSana Biotechnology, Inc. Stockholder News: Robbins LLP Reminds Investors of the Class Action Lawsuit Against SANAMarch 26 at 6:05 PM | globenewswire.comSANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMarch 26 at 4:00 PM | prnewswire.comROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANAMarch 26 at 3:07 PM | globenewswire.comSana Biotechnology (NASDAQ:SANA) Shares Down 8.5% - Should You Sell?Sana Biotechnology (NASDAQ:SANA) Trading Down 8.5% - Here's WhyMarch 26 at 1:28 PM | marketbeat.comShareholders that lost money on Sana Biotechnology, Inc. (SANA) should contact The Gross Law Firm about pending Class Action - SANAMarch 26 at 10:56 AM | globenewswire.comSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud LawsuitMarch 26 at 2:06 AM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers - SANAMarch 25 at 10:00 AM | prnewswire.comSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law FirmMarch 25 at 9:31 AM | prnewswire.comSana Biotechnology, Inc. (NASDAQ:SANA) Shares Acquired by Corient Private Wealth LLCCorient Private Wealth LLC increased its position in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 161.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,182,699 shares of the company's stock after purchasing an additional 7March 25 at 3:45 AM | marketbeat.comSana Biotechnology: High-Risk High-Reward With Breakthrough UP421March 25 at 12:01 AM | seekingalpha.comInvestor Alert: Robbins LLP Informs Investors of the Sana Biotechnology, Inc. Class Action LawsuitMarch 24, 2025 | prnewswire.comSANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMarch 24, 2025 | globenewswire.comRosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Large Losses to Contact the Firm for Information About Their RightsMarch 24, 2025 | businesswire.comINVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Sana Biotechnology, Inc. (SANA) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the FirmMarch 24, 2025 | globenewswire.comGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Sana Biotechnology, Inc. (SANA)March 24, 2025 | globenewswire.comSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. ...March 23, 2025 | gurufocus.comSANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law FirmMarch 23, 2025 | businesswire.comQ1 Earnings Forecast for SANA Issued By HC WainwrightMarch 22, 2025 | americanbankingnews.comWhat is HC Wainwright's Estimate for SANA Q1 Earnings?Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) - Analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Sana Biotechnology in a research note issued to investors on Tuesday, March 18th. HC Wainwright analyst E. Bodnar anticipates that the company will postMarch 21, 2025 | marketbeat.comCitizens Jmp Upgrades Sana Biotechnology (NASDAQ:SANA) to "Outperform"March 20, 2025 | americanbankingnews.comSana Biotechnology (NASDAQ:SANA) Sees Strong Trading Volume on Strong EarningsMarch 20, 2025 | americanbankingnews.comSana Biotechnology (NASDAQ:SANA) Sees Unusually-High Trading Volume on Strong EarningsSana Biotechnology (NASDAQ:SANA) Sees Unusually-High Trading Volume on Better-Than-Expected EarningsMarch 19, 2025 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Sana Biotechnology (NASDAQ:SANA)HC Wainwright reiterated a "buy" rating and issued a $11.00 price target on shares of Sana Biotechnology in a report on Tuesday.March 19, 2025 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Upgraded to Outperform at Citizens JmpCitizens Jmp upgraded shares of Sana Biotechnology from a "market perform" rating to an "outperform" rating and set a $5.00 price target for the company in a research report on Tuesday.March 19, 2025 | marketbeat.comSana Biotechnology, Inc. (NASDAQ:SANA) Given Average Rating of "Moderate Buy" by BrokeragesMarch 19, 2025 | americanbankingnews.comSana Biotechnology Faces Uncertainty as Financial Struggles Threaten Future OperationsMarch 19, 2025 | tipranks.comCitizens Capital Markets Upgrades Sana Biotechnology (SANA)March 19, 2025 | msn.comSana Biotechnology upgraded at Citizens despite Q4-led selloffMarch 18, 2025 | seekingalpha.comSana Biotechnology (NASDAQ:SANA) Issues Earnings Results, Misses Estimates By $0.01 EPSSana Biotechnology (NASDAQ:SANA - Get Free Report) posted its earnings results on Monday. The company reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.22) by ($0.01).March 18, 2025 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Issues Earnings ResultsSana Biotechnology (NASDAQ:SANA - Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.22) by ($0.01).March 18, 2025 | marketbeat.comSana Biotechnology, Inc: Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business UpdatesMarch 18, 2025 | finanznachrichten.deSana Biotechnology shares rise on narrower-than-expected lossMarch 18, 2025 | investing.comSana Biotechnology reports Q4 EPS (21c), consensus (24c)March 18, 2025 | markets.businessinsider.comSana Biotechnology upgraded to Outperform from Market Perform at Citizens JMPMarch 18, 2025 | markets.businessinsider.comSkandinaviska Enskilda Banken AB publ Sells 394,017 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA)Skandinaviska Enskilda Banken AB publ cut its stake in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 67.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 189,472 shares of the company's stoMarch 18, 2025 | marketbeat.comSana Biotechnology Reports 2024 Financial Results and ProgressMarch 18, 2025 | tipranks.comSana Biotechnology, Inc. Reports Positive 12-Week Clinical Results for Type 1 Diabetes Therapy and Financial Overview for Q4 2024March 17, 2025 | quiverquant.comSana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business UpdatesMarch 17, 2025 | globenewswire.comSana Biotechnology (NASDAQ:SANA) Shares Gap Up - Still a Buy?Sana Biotechnology (NASDAQ:SANA) Shares Gap Up - What's Next?March 15, 2025 | marketbeat.comSana Biotechnology, Inc. (NASDAQ:SANA) Given Consensus Recommendation of "Moderate Buy" by BrokeragesSana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has received an average recommendation of "Moderate Buy" from the five ratings firms that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have assiMarch 15, 2025 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Earns Buy Rating from Analysts at Jefferies Financial GroupJefferies Financial Group began coverage on shares of Sana Biotechnology in a report on Friday. They set a "buy" rating and a $7.00 price objective on the stock.March 15, 2025 | marketbeat.comJefferies Initiates Coverage of Sana Biotechnology (SANA) with Buy RecommendationMarch 15, 2025 | msn.comSana Biotechnology (NASDAQ:SANA) Shares Down 8.7% - What's Next?Sana Biotechnology (NASDAQ:SANA) Shares Down 8.7% - Here's What HappenedMarch 14, 2025 | marketbeat.comSana Biotechnology initiated with a Buy at JefferiesMarch 14, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Beam Therapeutics (BEAM)March 13, 2025 | markets.businessinsider.comSana Biotechnology (NASDAQ:SANA) Trading Up 9.7% - What's Next?Sana Biotechnology (NASDAQ:SANA) Stock Price Up 9.7% - What's Next?March 12, 2025 | marketbeat.com Remove Ads Get Sana Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter. Email Address SANA Media Mentions By Week SANA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SANA News Sentiment▼0.180.78▲Average Medical News Sentiment SANA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SANA Articles This Week▼244▲SANA Articles Average Week Remove Ads Get Sana Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARQT News Today TARS News Today HRMY News Today TVTX News Today JANX News Today AGIO News Today IRON News Today APGE News Today MESO News Today VERA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SANA) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sana Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sana Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
